Kyverna Therapeutics, Inc.
NASDAQ:KYTXBiotechnology
Healthcare
$4.48 -1.44%
-$0.12 today
- Market cap
- $283.23M
- Beta
- 1.96
- P/E (TTM)
- -3.1
- EPS (TTM)
- -$2.59
52W Low $2.52High $13.67
Volume 1.05M
Average 0.94M
Private 5-step workspace
Build a KYTX investment thesis
Turn Kyverna Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.